drugset / Trial / NCT00442585

S(+)-Ibuprofen Effects on Asprin Treated Volunteers

NCT00442585 ↗

Phase 1 Completed 72 enrolled Gebro Pharma GmbH
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this clinical trial is to determine whether S(+)-ibuprofen affect the platelet inhibition under steady state acetylsalicylic acid conditions.

Timeline

Start
2006-09
Primary completion
—
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule — —

Indications

No indication recorded.